Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2016 · 10-Q
Revenue$213.41M$213.41M−4.9% vs Q1 2015 Net Income-$267.00K-$267.00KN/M vs Q1 2015 EPS Diluted-$0.01-$0.01N/M vs Q1 2015 Gross Profit$102,539,000−3.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$9,250,000−32.7% Free Cash Flowderived-$14,996,000N/M Margins · derivedGross margin48.0%+0.7 pt vs Q1 2015
Operating margin1.7%+2.4 pt vs Q1 2015
Net margin-0.1%+1.5 pt vs Q1 2015
ended Jun 27, 2015 · filed Jul 30, 2015 · 33 d after period end